approval
saveBLUJEPA (GEPOTIDACIN MESYLATE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- recallAspen Biopharma Labs Pvt., Ltd. recall (Cls II)Mar 19, 2025
- approvalmomelotinib dihydrochloride: OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approvalApr 18, 2025
- approvalLAMOTRIGINE: LAMICTAL CD (LAMOTRIGINE) — FDA approvalApr 25, 2025
- approvalLAMOTRIGINE: LAMICTAL (LAMOTRIGINE) — FDA approvalApr 25, 2025
- approvalLAMOTRIGINE: LAMICTAL CD (LAMOTRIGINE) — FDA approvalApr 25, 2025
- approvalLAMOTRIGINE: LAMICTAL XR (LAMOTRIGINE) — FDA approvalApr 25, 2025
comments(0)
5-min edit window · permanent after that